Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4231 to 4245 of 8930 results

  1. NICE and health inequalities

    Health inequalities are differences in health across the population, and between different groups in society, that are systematic, unfair and avoidable.

  2. Epiretinal brachytherapy for wet age-related macular degeneration (HTG279)

    Evidence-based recommendations on epiretinal brachytherapy for wet age related macular degeneration. This involves using radiation therapy used to destroy the new blood vessels.

    HealthTech guidance
    Published
    16 December 2011
    View recommendations

    Sections for HTG279

  3. People and communities network application

    Home Get involved People and communities - putting you at the heart of our work {"@context":"http://schema.org","@type":"BreadcrumbList","itemLis

  4. Speaker request

    Home Events...

  5. Modern slavery and human trafficking statement

    Read NICE's statement on modern slavery and human trafficking.

  6. We care about our staff

    We support the wellbeing of our staff in a number of ways including an employee assistance programme, mental health first aiders and a variety of health and wellbeing activities.

  7. Diversity and inclusion

    We want people from all walks of life to contribute to our work and share their experience, expertise and passion.

  8. Diagnostics advisory committee

    Membership details, terms of reference, future meeting dates and past meeting minutes for our diagnostics advisory committee.

  9. Guidance and quality standards in consultation

    See a complete list of all our guidance and quality standards currently open for consultation

  10. Supporting the health and care system to implement virtual wards

    Virtual wards (also known as hospital at home) provide hospital level care at home.

  11. Mapping NICE guidelines to the CQC's single assessment framework

    This NICE resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.

  12. NICE International

    Providing an advisory service for international health organisations, ministries and government agencies whose task is to improve evidence-based decision making in health and social care

  13. Kidney conditions: CKD and SGLT2 inhibitors (IND324)

    This indicator covers the percentage of patients on the CKD register who are treated with an SGLT-2 inhibitor if they have: type 2 diabetes, or no type 2 diabetes and an eGFR 20 ml/min/1.73 m2 to 44 ml/min/1.73 m2 and are currently treated with an ACE inhibitor or angiotensin receptor blocker (ARB) (unless these are contraindicated) or an eGFR 45 ml/min/1.73 m2 to 59 ml/min/1.73 m2, are currently treated with an ACE inhibitor or ARB (unless these are contraindicated) and have a urine albumin-to-creatinine ratio (ACR) of 22.6 mg/mmol or more. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes.

    General practice indicators suitable for use in QOF
    Published
    18 February 2026

  14. Consultancy service

    Get expert advice and support from NICE International, part of the UK's National Institute for Health and Care Excellence, for a project in your country

  15. Diabetes: annual retinal screening (IND137)

    This indicator covers the percentage of patients with diabetes, on the register, who have a record of retinal screening in the preceding 12 month. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM98.

    General practice indicators suitable for use in QOF
    Last updated
    28 June 2022